Bixiye
QP57-18 New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary Angioedema
Taariikhda dhaqangalka Barnaamijka: Jul 19, 2018
Natiijooyinka Raadinta
Soo bandhiga 2341 - 2350 ee natiijooyinka 4234
Bixiye
QP49-18 Pharmacy Benefit Update - New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Triptans
Taariikhda wax ku ool ah ee barnaamijka: Jun 13, 2018
Bixiye
QP83-18 Cotiviti Healthcare Creates a Provider Connection Portal for Providers
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2018
Bixiye
QP39-18 Provider Cost Data Update
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2018
Bixiye
QP44-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Lyrica CR (pregabalin Extended Release)
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP40-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Selective Serotonin Inverse Agonist (SSIA)
Taariikhda uu dhaqangalayo Barnaamijka: May 31, 2018
Bixiye
QP30-18 Subscriber Identification (ID) Cards
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2018
Bixiye
QP11-18 Qualified Medicare Beneficiary Program Changes
Taariikhda uu dhaqangalayo Barnaamijka: 15, Feb 2018
Bixiye
QP31-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Metformin ER
Taariikhda uu dhaqangalayo Barnaamijka: May 04, 2018
Bixiye
QP53-18 Medical Drug Policy Criteria Expanded for Stelara and Simponi Aria
Taariikhda wax ku ool ah ee barnaamijka: Jun 27, 2018